Schedule 13G ownership disclosure

SUTRO BIOPHARMA INC

Security class unavailable · CUSIP: 869367102

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,997,453
Percent of class
3.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006662
Form type
SC 13G/A
Filer
Point72 Asset Management, L.P.
CIK
CIK 1603466
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub